Brassinosteroids and analogs as neuroprotectors: synthesis and structure-activity relationships

Steroids. 2012 Jan;77(1-2):91-9. doi: 10.1016/j.steroids.2011.10.009. Epub 2011 Oct 28.

Abstract

We have demonstrated previously that the brassinosteroid (BR) 24-epibrassinolide exerts neuroprotective effects deriving from its antioxidative properties. In this study, we synthesized 2 natural BRs and 5 synthetic analogs and analyzed their neuroprotective actions in neuronal PC12 cells, against 1-methyl-4-phenylpyridinium (MPP(+)), a neurotoxin known to induce oxidative stress and degenerescence of dopaminergic neurons characteristic of Parkinsonian brains. We also tested the neuroprotective potential of 2 commercially available BRs. Our results disclosed that 6 of the 9 BRs and analogs tested protected neuronal PC12 cells against MPP(+) toxicity. In addition, our structure-activity study suggests that the steroid B-ring and lateral chain play an important role for their neuroprotective action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / adverse effects*
  • Animals
  • Antioxidants / chemical synthesis*
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Brassinosteroids / chemical synthesis*
  • Brassinosteroids / pharmacology
  • Brassinosteroids / therapeutic use
  • Dopaminergic Neurons / cytology
  • Dopaminergic Neurons / drug effects*
  • Dopaminergic Neurons / metabolism
  • Humans
  • Molecular Structure
  • Neuroprotective Agents / chemical synthesis*
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Oxidative Stress
  • PC12 Cells
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology
  • Parkinson Disease / prevention & control*
  • Rats
  • Structure-Activity Relationship

Substances

  • Antioxidants
  • Brassinosteroids
  • Neuroprotective Agents
  • 1-Methyl-4-phenylpyridinium